Cargando…
Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Remodeling Pulmonary Microbiota
Chronic obstructive pulmonary disease (COPD) is one of the most common pulmonary diseases. Evidence suggests that dysbiosis of pulmonary microbiota leads to the COPD pathological process. Yifei Sanjie Formula (YS) is widely used to treat diseases in respiratory systems, yet little is known about its...
Autores principales: | Wu, Yueying, Meng, Hui, Qiao, Bo, Li, Ning, Zhang, Qiang, Jia, Wenqing, Xing, Haijing, Li, Yuqing, Yuan, Jiali, Yang, Zhongshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277004/ https://www.ncbi.nlm.nih.gov/pubmed/35847812 http://dx.doi.org/10.3389/fmed.2022.927607 |
Ejemplares similares
-
A Network Pharmacology Approach to Explore the Potential Mechanisms of Yifei Sanjie Formula in Treating Pulmonary Fibrosis
por: Qiao, Bo, et al.
Publicado: (2020) -
Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue
por: Wu, Yingchao, et al.
Publicado: (2023) -
Yifei sanjie Pills Alleviate Chemotherapy-Related Fatigue by Reducing Skeletal Muscle Injury and Inhibiting Tumor Growth in Lung Cancer Mice
por: Wu, Yingchao, et al.
Publicado: (2022) -
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
por: Chen, Wenmin, et al.
Publicado: (2023) -
Effect of Yifei-Huoxue Decoction Combined with Tiotropium on Inflammatory Cytokine Levels, Pulmonary Function, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
por: Sheng, Yunjiao, et al.
Publicado: (2022)